Infliximab in the treatment of rheumatoid arthritis

Author： Augustsson Jenny Jonsdottir Thorunn Klareskog Lars van Vollenhoven Ronald F

ISSN： 1745-509X

Source： Aging Health, Vol.2, Iss.1, 2006-02, pp. : 19-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab in the treatment of rheumatoid arthritis

By Pavelka Karel

Aging Health, Vol. 2, Iss. 4, 2006-08 ,pp. : 533-545

Future Medicine

Access to resources Recommend Favorite

By Laidmae Virve-Ines Leppik Lauri Tulva Taimi Haal Maire-Liis

Critical Public Health, Vol. 19, Iss. 1, 2009-03 ,pp. : 87-105

Routledge Ltd

Access to resources Recommend Favorite

The older rheumatoid arthritis patients: who are they and how should they be treated?

By Ranganath Veena K Amjadi Sogol Melikterminas Edmond Furst Daniel E

Aging Health, Vol. 6, Iss. 5, 2010-10 ,pp. : 533-549

Future Medicine

Access to resources Recommend Favorite

Case Report: 6-Year-Old Male with Autism and Systemic Onset Juvenile Rheumatoid Arthritis

By Williams Gail McChane Richard H. Schikler Ken

Journal of Developmental and Physical Disabilities, Vol. 16, Iss. 1, 2004-03 ,pp. : 117-123

Springer Publishing Company

Access to resources Recommend Favorite

Patient delays in seeking help at the onset of rheumatoid arthritis: the problem, its causes and potential solutions

By Stack Rebecca J Simons Gwenda Kumar Kanta Mallen Christian D Raza Karim

Aging Health, Vol. 9, Iss. 4, 2013-08 ,pp. : 425-435

Future Medicine

Access to resources Recommend Favorite